In conclusion, when all stages and histologies are considered, there is a trend for COX-2 overexpression as a prognostic factor for survival in patients with NSCLC, but there is a high heterogeneity between the studies and these results are not statistically significant. Here, PTGS2 is linked to non-small cell lung carcinoma.